We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-4.02%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$137M
AUM Growth
-$20.6M
Cap. Flow
-$9.46M
Cap. Flow %
-6.93%
Top 10 Hldgs %
79.12%
Holding
33
New
2
Increased
5
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.21M
2
IBB icon
iShares Biotechnology ETF
IBB
+$1.87M
3
BABA icon
Alibaba
BABA
+$1.62M
4
AMZN icon
Amazon
AMZN
+$662K
5
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$484K

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$13.9M
2
WYNN icon
Wynn Resorts
WYNN
+$2.01M
3
C icon
Citigroup
C
+$1.34M
4
BHC icon
Bausch Health
BHC
+$1.11M
5
ISRG icon
Intuitive Surgical
ISRG
+$981K

Sector Composition

Rank Sector Weight
1 Healthcare 49.12%
2 Consumer Discretionary 18.07%
3 Communication Services 6.08%
4 Technology 4.07%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$31.4M 22.97%
525,755
– –
TSLA icon
2
CALL
Tesla
TSLA
$1.18T
$22.9M 16.8%
1,008,375
+123,375
+14% +$2.85M
AMZN icon
3
Amazon
AMZN
$2.44T
$17.6M 12.88%
365,740
+13,480
+4% +$662K
META icon
4
Meta Platforms (Facebook)
META
$1.49T
$8.3M 6.08%
55,000
– –
XBI icon
5
State Street SPDR S&P Biotech ETF
XBI
$10B
$6.06M 4.44%
70,000
+40,000
+133% +$3.21M
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
$5.42M 3.97%
1,671,956
– –
AVDL
7
DELISTED
Avadel Pharmaceuticals
AVDL
$4.67M 3.42%
444,439
– –
BABA icon
8
Alibaba
BABA
$276B
$4.32M 3.16%
25,000
+10,000
+67% +$1.62M
MSFT icon
9
Microsoft
MSFT
$2.9T
$3.95M 2.89%
53,000
-12,000
-18% -$877K
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.43M 2.51%
270,775
– –
BSTC
11
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.43M 2.51%
73,649
– –
CBM
12
DELISTED
Cambrex Corporation
CBM
$2.78M 2.04%
50,519
– –
CMG icon
13
Chipotle Mexican Grill
CMG
$43.9B
$2.77M 2.03%
450,000
– –
NVLN
14
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.22M 1.63%
315,980
– –
JNP
15
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.16M 1.58%
426,903
– –
ISRG icon
16
Intuitive Surgical
ISRG
$127B
$2.09M 1.53%
18,000
-9,000
-33% -$981K
IBB icon
17
iShares Biotechnology ETF
IBB
$9.45B
$1.94M 1.42%
+17,484
New +$1.87M
CPIX icon
18
Cumberland Pharmaceuticals
CPIX
$99.8M
$1.86M 1.36%
263,881
– –
LGND icon
19
Ligand Pharmaceuticals
LGND
$5.77B
$1.82M 1.34%
21,482
– –
MU icon
20
Micron Technology
MU
$835B
$1.61M 1.18%
41,000
+5,000
+14% +$158K
ANIP icon
21
ANI Pharmaceuticals
ANIP
$1.86B
$1.56M 1.14%
29,722
– –
ALIM
22
DELISTED
Alimera Sciences
ALIM
$1.3M 0.96%
64,400
– –
ARLZ
23
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$663K 0.49%
289,664
-30,000
-9% -$40.2K
ADVM
24
DELISTED
Adverum Biotechnologies
ADVM
$652K 0.48%
17,865
– –
PETQ
25
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$542K 0.4%
+20,000
New +$484K
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, JW Asset Management held 33 positions worth $137M, down 13% from $157M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

JW Asset Management withdrew a net $9.46M in Q3 2017, closing 4 positions and reducing 3 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in iShares Biotechnology ETF worth $1.94M.

  • JW Asset Management's largest Q3 2017 buy was iShares Biotechnology ETF: 17,484 shares worth $1.94M.
  • JW Asset Management added most to State Street SPDR S&P Biotech ETF in Q3 2017, an estimated $3.21M increase.
  • JW Asset Management's biggest Q3 2017 reduction was Intuitive Surgical, cutting an estimated $981K.
  • JW Asset Management fully exited Alphabet (Google) Class A in Q3 2017, selling an estimated $13.9M.
  • JW Asset Management's ten largest holdings make up 79% of its $137M portfolio in Q3 2017.
  • JW Asset Management opened 2 new positions and closed 4 in Q3 2017.
  • JW Asset Management's portfolio value fell 13% quarter-over-quarter to $137M.

Based on JW Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.